New York-listed Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has launched an underwritten public offering of…
Italy: Stevanato launches US$300m underwritten public offering
…
…






